Feng Shi, Ph.D.

Feng ShiPostdoctoral Associate

Feng Shi joined the lab as a postdoc in 2011. Before that, he used to work with the PD-1/PD-L1 coinhibitory pathway in CD8+T cells, regarding the aspect of human hepatic immunology. Now his work focuses on identifying potential therapeutic targets in human follicular lymphoma by using novel humanized mouse techniques. He believes that humanized mouse could be of great help for mimicking human disease within a more human-relative system, which, in turn, would be invaluable in development of disease treatment in the future.

Contact Information